View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Oak Valley Community Bank Announces Branch Manager Hiring

Oak Valley Community Bank Announces Branch Manager Hiring OAKDALE, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Oak Valley Community Bank, a wholly-owned subsidiary of Oak Valley Bancorp (NASDAQ: OVLY), announced that Mariam Shah has joined the bank as Vice President, Branch Manager of the Lodi Branch which is located at 31 South School Street and is slated to open later this summer. Shah brings over a decade of banking experience to her new role, including the past three years as a Branch Manager at another financial institution. She will oversee daily branch operations and focus on buil...

 PRESS RELEASE

Oak Valley Bancorp and Oak Valley Community Bank Announce Director Ret...

Oak Valley Bancorp and Oak Valley Community Bank Announce Director Retirements and New Director Appointment OAKDALE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Oak Valley Bancorp (NASDAQ: OVLY) (the “Company”), the bank holding company for Oak Valley Community Bank (the “Bank”) announced the retirement of Thomas A. Haidlen and Danny L. Titus from the Bank and Company’s Boards of Directors, effective June 17, 2025. Concurrently, Erich A. Haidlen accepted his appointment to the Board of Directors of the Company and the Bank. T. Haidlen and Titus joined the board of Oak Valley Community Ba...

 PRESS RELEASE

Dorman announces planned retirement of Chief Financial Officer David M...

Dorman announces planned retirement of Chief Financial Officer David M. Hession COLMAR, Pa., June 05, 2025 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (“Dorman” or the “Company”) (NASDAQ:DORM) announced today that David M. Hession, Senior Vice President and Chief Financial Officer, has informed Dorman of his plans to retire later this year. The Company has initiated a comprehensive search process with the assistance of a leading executive search firm to identify Mr. Hession’s successor. Mr. Hession will remain in his position until a successor is in place and will serve in an advisory role ...

Novocure Ltd: 1 director

A director at Novocure Ltd sold 30,196 shares at 17.499USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Kimberly-Clark Corporation and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 28 May 2025 in which we reassessed the appropriateness of the ratings in the con...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
BLDR BUILDERS FIRSTSOURCE INC.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
PINS PINTEREST INC. CLASS A
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
APRE APREA THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
UFPI UFP INDUSTRIES INC.
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
PLTK PLAYTIKA HOLDING
NUVB NUVATION BIO INC (A)
RBLX ROBLOX
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
TCRX TSCAN THERAPEUTICS INC
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
NUVL NUVALENT INC
ARTV ARTIVA BIOTHERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
BCAX BICARA THERAPEUTICS INC.
David Nierengarten ... (+8)
  • David Nierengarten
  • Dennis Pak
  • Dylan Shindler
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Yun Zhong
David Nierengarten ... (+3)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
 PRESS RELEASE

Dorman’s Light Duty automotive segment announces more first-to-afterma...

Dorman’s Light Duty automotive segment announces more first-to-aftermarket repair solutions COLMAR, Pa., May 29, 2025 (GLOBE NEWSWIRE) -- The Light Duty business segment of Dorman Products, Inc. (NASDAQ:DORM) is announcing the release of hundreds of new automotive repair solutions this month, many of which are first-to-the-aftermarket products. These products join a growing Dorman catalog of over 138,000 SKUs. They offer approximately 12+ million new sales opportunities for aftermarket parts distributors, retailers and repair shops, and more accessible solutions for vehicle owners. May’s...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch